IRIS Accounts Production v25.1.0.734 09555909 Board of Directors 1.11.23 31.10.24 31.10.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095559092023-10-31095559092024-10-31095559092023-11-012024-10-31095559092022-10-31095559092022-11-012023-10-31095559092023-10-3109555909ns15:EnglandWales2023-11-012024-10-3109555909ns14:PoundSterling2023-11-012024-10-3109555909ns10:Director12023-11-012024-10-3109555909ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3109555909ns10:SmallEntities2023-11-012024-10-3109555909ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3109555909ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3109555909ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3109555909ns10:FullAccounts2023-11-012024-10-310955590912023-11-012024-10-3109555909ns10:Director22023-11-012024-10-3109555909ns10:RegisteredOffice2023-11-012024-10-3109555909ns5:CurrentFinancialInstruments2024-10-3109555909ns5:CurrentFinancialInstruments2023-10-3109555909ns5:Non-currentFinancialInstruments2024-10-3109555909ns5:Non-currentFinancialInstruments2023-10-3109555909ns5:ShareCapital2024-10-3109555909ns5:ShareCapital2023-10-3109555909ns5:RetainedEarningsAccumulatedLosses2024-10-3109555909ns5:RetainedEarningsAccumulatedLosses2023-10-3109555909ns5:NetGoodwill2023-11-012024-10-3109555909ns5:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3109555909ns5:ComputerSoftware2023-11-012024-10-3109555909ns5:LandBuildings2023-11-012024-10-3109555909ns5:PlantMachinery2023-11-012024-10-3109555909ns5:NetGoodwill2023-10-3109555909ns5:IntangibleAssetsOtherThanGoodwill2023-10-3109555909ns5:NetGoodwill2024-10-3109555909ns5:IntangibleAssetsOtherThanGoodwill2024-10-3109555909ns5:NetGoodwill2023-10-3109555909ns5:IntangibleAssetsOtherThanGoodwill2023-10-3109555909ns5:LandBuildings2023-10-3109555909ns5:PlantMachinery2023-10-3109555909ns5:LandBuildings2024-10-3109555909ns5:PlantMachinery2024-10-3109555909ns5:LandBuildings2023-10-3109555909ns5:PlantMachinery2023-10-3109555909ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3109555909ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-31
REGISTERED NUMBER: 09555909 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2024

for

Clare Healthcare Limited

Clare Healthcare Limited (Registered number: 09555909)

Contents of the Financial Statements
for the Year Ended 31 October 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Clare Healthcare Limited

Company Information
for the Year Ended 31 October 2024







DIRECTORS: Mr Sanjit Singh Clare
Dr Manoj Dhanda





REGISTERED OFFICE: 8 Pakenham Road
Birmingham
B15 2NE





REGISTERED NUMBER: 09555909 (England and Wales)





ACCOUNTANTS: Dhillon Accountants Limited
Chartered Accountants
Office 1
21 Hatherton Street
Walsall
WS4 2LA

Clare Healthcare Limited (Registered number: 09555909)

Balance Sheet
31 October 2024

31.10.24 31.10.23
Notes £    £   
FIXED ASSETS
Intangible assets 4 1,260,239 1,353,402
Tangible assets 5 110,408 65,949
1,370,647 1,419,351

CURRENT ASSETS
Stocks 80,000 100,652
Debtors 6 468,138 329,843
Cash at bank and in hand 77,682 239,432
625,820 669,927
CREDITORS
Amounts falling due within one year 7 (1,183,400 ) (1,110,472 )
NET CURRENT LIABILITIES (557,580 ) (440,545 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

813,067

978,806

CREDITORS
Amounts falling due after more than
one year

8

(796,337

)

(923,646

)
NET ASSETS 16,730 55,160

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 16,728 55,158
SHAREHOLDERS' FUNDS 16,730 55,160

Clare Healthcare Limited (Registered number: 09555909)

Balance Sheet - continued
31 October 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 May 2025 and were signed on its behalf by:





Mr Sanjit Singh Clare - Director


Clare Healthcare Limited (Registered number: 09555909)

Notes to the Financial Statements
for the Year Ended 31 October 2024


1. STATUTORY INFORMATION

Clare Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2016, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of four years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - not provided
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Clare Healthcare Limited (Registered number: 09555909)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2023 - 15 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
At 1 November 2023
and 31 October 2024 1,860,000 4,130 1,864,130
AMORTISATION
At 1 November 2023 507,250 3,478 510,728
Charge for year 93,000 163 93,163
At 31 October 2024 600,250 3,641 603,891
NET BOOK VALUE
At 31 October 2024 1,259,750 489 1,260,239
At 31 October 2023 1,352,750 652 1,353,402

Clare Healthcare Limited (Registered number: 09555909)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024


5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 November 2023 20,784 114,578 135,362
Additions - 62,160 62,160
At 31 October 2024 20,784 176,738 197,522
DEPRECIATION
At 1 November 2023 - 69,413 69,413
Charge for year - 17,701 17,701
At 31 October 2024 - 87,114 87,114
NET BOOK VALUE
At 31 October 2024 20,784 89,624 110,408
At 31 October 2023 20,784 45,165 65,949

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Trade debtors 360,123 245,019
Other debtors 108,015 84,824
468,138 329,843

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Bank loans and overdrafts 182,077 182,771
Trade creditors 388,163 401,844
Taxation and social security 19,493 18,380
Other creditors 593,667 507,477
1,183,400 1,110,472

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.10.24 31.10.23
£    £   
Bank loans 796,337 923,646

Clare Healthcare Limited (Registered number: 09555909)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
31.10.24 31.10.23
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 796,337 923,646

9. RELATED PARTY DISCLOSURES

As of 31 October 2024, the company owed £149,942 to Gohil Chemists Ltd ('Goh').
As of 31 October 2024, the company owed £62,000 to Clare Locum Services Limited ('Cla').
As of 31 October 2024, the company owed £19,509 to Pendeford Healthcare Limited ('Pen').

All loans are payable on demand.

Mr SS Clare and Dr M Dhanda were the directors of 'Goh' and 'Pen' as of 31 October 2024.
Mr SS Clare was also the sole director of 'Cla' as of 31 October 2024.

10. ULTIMATE CONTROLLING PARTY

The company's ultimate controlling parties are directors Mr SS Clare and Dr M Dhanda by virtue of their ownership of 100% of the issued share capital in the company.